NO20080088L - Sterkt biotilgjengelige orale forsinkede frigjoringsformer av O-desmetylvenlafaksin - Google Patents

Sterkt biotilgjengelige orale forsinkede frigjoringsformer av O-desmetylvenlafaksin

Info

Publication number
NO20080088L
NO20080088L NO20080088A NO20080088A NO20080088L NO 20080088 L NO20080088 L NO 20080088L NO 20080088 A NO20080088 A NO 20080088A NO 20080088 A NO20080088 A NO 20080088A NO 20080088 L NO20080088 L NO 20080088L
Authority
NO
Norway
Prior art keywords
approx
desmethylvenlafaxine
hours
delayed release
release
Prior art date
Application number
NO20080088A
Other languages
English (en)
Norwegian (no)
Inventor
Christopher Richard Diorio
Mahdi B Fawzi
Syed Muzafar Shah
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20080088L publication Critical patent/NO20080088L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20080088A 2005-07-15 2008-01-07 Sterkt biotilgjengelige orale forsinkede frigjoringsformer av O-desmetylvenlafaksin NO20080088L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69962305P 2005-07-15 2005-07-15
PCT/US2006/027106 WO2007011619A2 (en) 2005-07-15 2006-07-13 Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate

Publications (1)

Publication Number Publication Date
NO20080088L true NO20080088L (no) 2008-04-02

Family

ID=37669348

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080088A NO20080088L (no) 2005-07-15 2008-01-07 Sterkt biotilgjengelige orale forsinkede frigjoringsformer av O-desmetylvenlafaksin

Country Status (20)

Country Link
US (1) US20070014859A1 (https=)
EP (1) EP1904040A2 (https=)
JP (1) JP2009501233A (https=)
KR (1) KR20080025405A (https=)
CN (1) CN101247791A (https=)
AR (1) AR054833A1 (https=)
AU (1) AU2006270315A1 (https=)
BR (1) BRPI0613484A2 (https=)
CA (1) CA2612960A1 (https=)
CR (1) CR9626A (https=)
EC (1) ECSP088106A (https=)
GT (1) GT200600307A (https=)
IL (1) IL188313A0 (https=)
MX (1) MX2008000666A (https=)
NO (1) NO20080088L (https=)
PE (1) PE20070192A1 (https=)
RU (1) RU2007148195A (https=)
SV (1) SV2008002612A (https=)
TW (1) TW200740427A (https=)
WO (1) WO2007011619A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101313702B1 (ko) 2005-02-03 2013-10-04 와이어쓰 제피티니브 및/또는 에를로티니브 내성암 치료용 약제학적 조성물
DE602006010343D1 (de) * 2005-03-31 2009-12-24 Wyeth Corp Kombinationsprodukt aus o-desmethylvenlafaxin und bazedoxifen und verwendungen davon
US20080175873A1 (en) * 2005-06-02 2008-07-24 Biovail Laboratories International S.R.L. Modified release composition of at least one form of venlafaxine
EP1942937A1 (en) 2005-11-04 2008-07-16 Wyeth Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272
CA2629609A1 (en) * 2005-12-05 2007-06-14 Wyeth Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
TW200806282A (en) * 2006-05-05 2008-02-01 Wyeth Corp Solid dosage formulations
TR200909798T1 (tr) * 2007-07-12 2010-05-21 Dr. Reddy's Laboratories Ltd. O-desmetilvenlafaksin.
CA2702664A1 (en) * 2007-10-16 2009-04-23 Alphapharm Pty Ltd Controlled-release pharmaceutical formulation
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
BRPI0722303A2 (pt) * 2007-12-10 2014-04-22 Wyeth Llc O-desmatil-venlafaxina para tratar transtorno depressivo maior
BRPI0914790A2 (pt) 2008-06-17 2015-10-20 Wyeth Llc uso de um composto de vinorelbina e um composto de hki-272, composição farmacêutica e produto e kit para o tratamento de neoplasma
US8669273B2 (en) 2008-08-04 2014-03-11 Wyeth Llc Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
CN101716168B (zh) * 2008-10-09 2014-09-17 北京德众万全医药科技有限公司 一种含有去甲文拉法新的盐的药物组合物及其制备方法
EP2191822A1 (en) 2008-11-26 2010-06-02 LEK Pharmaceuticals d.d. Controlled release pharmaceutical compositions comprising O-desmethyl-venlafaxine
DK3000467T3 (da) 2009-04-06 2023-03-27 Wyeth Llc Behandling med neratinib mod brystkræft
CA2780332C (en) 2009-11-09 2018-01-30 Wyeth Llc Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
MX2012010659A (es) 2010-03-31 2013-03-05 Wockhardt Ltd Composicion farmaceutica de liberacion modificada que comprende desvenlafaxina o sus sales.
CN102085197B (zh) * 2010-12-14 2013-08-14 北京万生药业有限责任公司 一种文拉法辛缓释制剂及其制备方法
KR20140030156A (ko) 2011-04-12 2014-03-11 루핀 리미티드 방출-조절되는 데스벤라팍신 약학 조성물
CN111008356B (zh) * 2019-11-13 2023-06-16 成都理工大学 一种基于WTSVD算法扣除背景的γ能谱集分析方法
CN114288273B (zh) * 2022-02-11 2022-10-18 桂林华信制药有限公司 一种盐酸文拉法辛缓释胶囊及其生产工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
WO2000076955A1 (en) * 1999-06-15 2000-12-21 American Home Products Corporation Enantiomers of o-desmethyl venlafaxine
AR021347A1 (es) * 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
US20030190352A1 (en) * 2002-03-28 2003-10-09 Synthon Bv Compositions of venlafaxine base
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
ES2277030T3 (es) * 2003-05-02 2007-07-01 Dexcel Ltd. Formulacion en comprimidos de venlafaxina de liberacion prolongada.
AU2005212166A1 (en) * 2004-02-06 2005-08-25 Wyeth Multiparticulate O-desmethylvenlafaxine salts and uses thereof
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology

Also Published As

Publication number Publication date
WO2007011619A2 (en) 2007-01-25
MX2008000666A (es) 2008-03-13
US20070014859A1 (en) 2007-01-18
SV2008002612A (es) 2008-08-29
EP1904040A2 (en) 2008-04-02
BRPI0613484A2 (pt) 2016-11-16
CR9626A (es) 2008-04-10
KR20080025405A (ko) 2008-03-20
CA2612960A1 (en) 2007-01-25
GT200600307A (es) 2008-04-24
WO2007011619A3 (en) 2007-06-21
JP2009501233A (ja) 2009-01-15
RU2007148195A (ru) 2009-08-20
PE20070192A1 (es) 2007-03-16
CN101247791A (zh) 2008-08-20
ECSP088106A (es) 2008-02-20
IL188313A0 (en) 2008-04-13
TW200740427A (en) 2007-11-01
AU2006270315A1 (en) 2007-01-25
AR054833A1 (es) 2007-07-18

Similar Documents

Publication Publication Date Title
NO20080088L (no) Sterkt biotilgjengelige orale forsinkede frigjoringsformer av O-desmetylvenlafaksin
CN102036649A8 (zh) 精氨酸盐及其治疗口腔疾病的用途
CA3094580C (en) Oral formulations of cytidine analogs and methods of use thereof
SE0501556L (sv) Förstärkt absorption
NO2017005I1 (no) Human pappilomavirus vaksine [type 6, 11, 16, 18, 31, 33, 45, 52, 58]
WO2007022518A3 (en) New uses of glucoregulatory proteins
NO20064670L (no) Galeniske formuleringer av organiske forbindelser
WO2006105112A3 (en) Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people
IL178432A0 (en) Human glp-1 mimetibodies, compositions, methods and uses
MY146969A (en) Dpp iv inhibitor formulations
UA94221C2 (en) Lipocalin protein
WO2008022974A3 (fr) Composition antidiabetique contenant de l'acide chicorique et/ou l'un de ses metabolites
SG178975A1 (en) Indenone derivative and pharmaceutical composition comprising same
MX2010000266A (es) Un método para disminuir los síntomas del consumo de alcohol.
IL191758A0 (en) Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
WO2009117401A8 (en) Compositions for site-specific delivery of imatinib and methods of use
ATE437679T1 (de) Wässrige antitranspirant formulierung
NO20070522L (no) Oral vedvarende frigivelsesformulering av tedisamil med gastriske bibeholdelsesegenskaper
WO2008073863A3 (en) Preparation and utility of substituted allylamines
UA102111C2 (uk) Фармацевтична композиція у вигляді разової пероральної дози, що містить леводопу, карбідопу і ентакапон або їх солі
WO2006048261A3 (en) Oral solid dosage forms containing a low dose of estradiol
FR2887447B1 (fr) Utilisation d'un peptide comme principe actif amincissant
EA200802262A1 (ru) Назальные и буккальные композиции для борьбы с храпом
TW200640446A (en) Prophylactic anti-stress agent
WO2011055033A3 (fr) Utilisation d'un hydrolysat peptidique de maïs en tant qu'agent actif stimulant la pousse du cheveu

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application